Science Corp moves toward first human brain sensor implant
Science Corp, led by Max Hodak, is preparing to place its first sensor in a human brain — a key step that advances restorative neurotechnology from the lab toward patients. The small sensor is designed not only to monitor brain activity but also to deliver targeted, gentle electrical stimulation aimed at encouraging healing in damaged neural tissue.
The company highlights an early therapeutic use: providing controlled electrical pulses to injured brain or spinal cord cells to promote repair. This approach could complement existing rehabilitation methods and offers a promising route for people recovering from spinal cord injuries, stroke, or other neurological damage.
Beyond immediate therapeutic potential, the implant represents a broader win for the neurotech field: it demonstrates progress on safety, miniaturization, and targeted stimulation capabilities that are needed for clinically viable devices. Early human placements are critical for gathering real-world data on efficacy and safety and for iterating toward practical, patient-focused treatments.
Next steps will focus on careful clinical monitoring and trials to validate benefits and refine protocols. If the sensor proves safe and effective, it could expand treatment options for many patients and accelerate development of next-generation neurotherapies.